Investigation of genetic risk factors associated with alcoholism

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 9 SUPPL., 1996, Pages

  Harada, Shoji ^a   Okubo, Takehito ^a   Tsutsumi, Mikihiro ^b   Takase, Shujiro ^b   Muramatsu, Taro ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KURIHAMA NATIONAL HOSPITAL   (Japan)

Author keywords

Alcoholism; Cholecystokinin B Receptor; Mitochondrial DNA; Polymorphism; Serotonin 1A Receptor

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALCOHOL; CHOLECYSTOKININ B RECEPTOR;

ADULT; ALCOHOLISM; ALLELE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CONFERENCE PAPER; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; DNA SEQUENCE; EXON; GENE EXPRESSION; GENETIC DISORDER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

ALCOHOLISM; BASE SEQUENCE; CHROMOSOME DELETION; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; GENETIC MARKERS; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; POLYMERASE CHAIN REACTION; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; RECOMBINATION, GENETIC;

EID: 0030468021     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01160.x     Document Type: Conference Paper

References (20)

1. Goodwin DW: The genetics of alcoholism. Subst Alcohol Actions Misuse 1:101-117, 1980
2. Deitrich RA, Spuhler K: Genetics of alcoholism and alcohol actions, in Smart RG, Cappel HD, Glaser FB, Israel Y, Kalant H, Popham RE, Schmit W, Sellers EM (eds): Research Advances in Alcohol and Drug Problems, vol 8. New York, Plenum Publishing Corp., 1984, pp 47-97
3. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaram P, Nogami H, Briggs AH, Cohn JB: Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055-2060, 1990
4. Noble PE, Blum K, Ritchie T, Montgomery A, Sheridan PJ: Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48:648-654, 1991
5. Noble EP, Syndulko K, Fitch RJ, Ritchie T, Bohlman MC, Guth P, Sheridan PJ, Montogomery A, Heinzman C, Sparkes RS, Blum K: D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. Alcohol Alcohol 29:729-744, 1994
6. Bolos AM, Dean M, Lucas-Deres S, Ramsburg M, Brown GL, Goldman D: Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA 263: 3156-3160, 1990
7. Gelemter J, O'Malley S, Risch N, Kranzier HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK: No association between an allele at the dopamine D2 receptor gene (DRD2) and alcoholism. JAMA 264:1801-1807, 1991
8. Propping P, Nöthen MM: Genetic variation of CNS receptors-A new perspective for pharmacogenetics. Pharmacogenetics 5:318-325,1995
9. Luft R: The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:8731-8738, 1994
10. Takada A, Japanese Study Group for Alcoholic Liver Disease: A new diagnostic criterion of alcoholic liver disease. Acta Hepatol 34:888-896, 1993
11. Song I, Brown DR, Wiltshire RN, Ganz I, Trent JM: The human gastrin/cholecystokinin type B receptor gene: Alternative splice donor site in exon 4 generates two variant mRNAs. Proc Natl Acad Sci USA 90: 9085-9089, 1993
12. Kobilka B, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Franke U, Leftkowitz RJ, Caron MG: An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329:75-79, 1987
13. Anderson S, Bankier AT, Barrell BG, de Bruijin MHL, Coulson AR, Drouin J, Eperson IC, Nielich DP, Roe BA, Sanger F, Schrier DH, Smith JH, Standen R, Young IG: Sequence and organization of the human mitochondrial genome. Nature 290:457-465, 1981
14. Crawley J: Cholecystokinin-dopamine interactions. Trends Pharmacol Sci 12:232-236, 1991
15. Moran TH, Robinson PH, Goldrich MS, McHugh PR: Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res 362:175-179, 1986
16. Crawley JN: Modulation of mesolimbic dopaminergic behaviors by cholecystokinin, in Koivals PW, Nemeroff CB (eds): The Mesocorticolimbic Dopamine System. New York, Annals of the New York Academy of Sciences, 1988, pp 381-396
17. Nakhai B, Nielsen DA, Linnoila M, Goldman D: Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: Glycine 22 to serine 22 and isoleucinc 28 to valine 28. Biochem Biophys Res Commun 210:530-536, 1995
18. Ho BY, Karschin A, Branchek T, Davidson N, Lester HA: The role of conversed aspartate and serine residues in ligand binding and in function of the 5-HT1A receptor: A site-directed mutation study. FEBS Lett 312:259-262, 1992
19. Matthews PM, Brown RM, Morten K, Marchington D, Poulton J, Brown G: Intracellular heteroplasmy for disease-associated point mutations in mtDNA: Implications for disease expression and evidence for mitotic segregation heteroplasmic units of mtDNA. Hum Genet 96:261-268, 1995
20. Rötig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F, Romero N, Schmitz J, Rustin P, Fischer A, Saudubray JM, Munnich A: Pearson's marrow-Pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest 86:1601-1608, 1990